263 related articles for article (PubMed ID: 21916166)
1. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
Popova NF
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166
[No Abstract] [Full Text] [Related]
2. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Castillo-Trivino T; Lopetegui I; Alarcón-Duque JA; López de Munain A; Olascoaga J
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):931-2. PubMed ID: 25835036
[No Abstract] [Full Text] [Related]
3. New drugs may improve, complicate treatment for multiple sclerosis.
Link H; Martin R
Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513
[No Abstract] [Full Text] [Related]
4. Trial watch: Phase III promise for oral multiple sclerosis therapy.
Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180099
[No Abstract] [Full Text] [Related]
5. Fingolimod for multiple sclerosis.
Pelletier D; Hafler DA
N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
[No Abstract] [Full Text] [Related]
6. Fingolimod: cardiovascular deaths.
Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515137
[No Abstract] [Full Text] [Related]
7. Fingolimod and multiple sclerosis: four cautionary tales.
Bourdette D; Gilden D
Neurology; 2012 Nov; 79(19):1942-3. PubMed ID: 23035058
[No Abstract] [Full Text] [Related]
8. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
Komoly S
Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
[No Abstract] [Full Text] [Related]
9. Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Tully T; Barkley A; Silber E
Neurology; 2015 May; 84(19):1999-2001. PubMed ID: 25878178
[No Abstract] [Full Text] [Related]
10. [Disease modifying drugs in multiple sclerosis and pregnancy].
Tur C; Tintoré M; Aguilera C
Med Clin (Barc); 2012 Sep; 139(7):316-8. PubMed ID: 22743277
[No Abstract] [Full Text] [Related]
11. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
Klatt J; Hartung HP; Hohlfeld R
Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
[TBL] [Abstract][Full Text] [Related]
12. Tumefactive multiple sclerosis and fingolimod.
Lovera J; Villemarette-Pittman N
J Neurol Sci; 2014 Sep; 344(1-2):1-2. PubMed ID: 24993468
[No Abstract] [Full Text] [Related]
13. Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Sato DK; Callegaro D
Arq Neuropsiquiatr; 2014 Sep; 72(9):651-2. PubMed ID: 25252227
[No Abstract] [Full Text] [Related]
14. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
Ward MD; Jones DE; Goldman MD
Expert Opin Drug Saf; 2014 Jul; 13(7):989-98. PubMed ID: 24935480
[TBL] [Abstract][Full Text] [Related]
15. [Fingolimod treatment in multiple sclerosis].
Tanaka M
Nihon Rinsho; 2014 Nov; 72(11):2010-4. PubMed ID: 25518386
[TBL] [Abstract][Full Text] [Related]
16. [New disease-modifying and symptomatic therapies for multiple sclerosis].
Weise G; Buttmann M
MMW Fortschr Med; 2012 Apr; 154(7):64-6. PubMed ID: 22558878
[No Abstract] [Full Text] [Related]
17. Fingolimod-associated amenorrhea: a report of three cases.
Alroughani R
Mult Scler; 2014 Oct; 20(12):1662-4. PubMed ID: 24515730
[TBL] [Abstract][Full Text] [Related]
18. Gilenya safety update: cardiac and macula.
Huggins A; Sergott RC
Curr Opin Ophthalmol; 2012 Nov; 23(6):457-9. PubMed ID: 23047163
[No Abstract] [Full Text] [Related]
19. The pill times 2: what every woman with multiple sclerosis should know.
Langer-Gould AM
Neurology; 2014 Feb; 82(8):654-5. PubMed ID: 24463629
[No Abstract] [Full Text] [Related]
20. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.
Voon V; Saiva L; O'Kelly S; Keane D
Eur J Clin Pharmacol; 2014 Mar; 70(3):373-5. PubMed ID: 24309839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
